Effect of Biofeedback Activation on Balance in Osteoporotic Elderly
NCT ID: NCT07333989
Last Updated: 2026-01-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
60 participants
INTERVENTIONAL
2026-01-02
2026-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gait and Paraspinal sEMG in Degenerative Spinal Diseases
NCT07309926
Effect of Core Stability and Sensorimotor Training Exercises on Postural Stability Post Lower Limb Burn
NCT06718829
Investigation of the Effects of Lumbopelvic Movement Training on Different Parameters in Healthy Sedentary Individuals
NCT07019376
Effect of Upper Limb Ergometer on the AIP in Post Menopausal Obese Women.
NCT04676074
Effect of Bone on Vibration-Induced Muscle Electrical Activity
NCT01367041
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Gluteus medius isometric strengthening using EMG with traditional balance training
received 30 minutes of traditional balance training (functional strength, static and dynamic balance, and gait training) followed by 30 minutes of gluteus medius isometric strengthening using EMG biofeedback, three times per week, for four consecutive weeks.
Electromyographic (EMG) biofeedback
a physical therapy intervention that uses auditory and visual feedback to control the contraction or relaxation of muscles. Repeated biofeedback training can induce motor learning of muscles. Biofeedback enhances the function of pelvic floor muscles by enhancing the force generation, correct timing, and coordination of the pelvic floor muscles. Electromyography Biofeedback is considered as a behavioural therapy training modality
Traditional balance training only
received balance training alone with the same frequency and duration.
Balance training
functional strength, static and dynamic balance, and gait training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Electromyographic (EMG) biofeedback
a physical therapy intervention that uses auditory and visual feedback to control the contraction or relaxation of muscles. Repeated biofeedback training can induce motor learning of muscles. Biofeedback enhances the function of pelvic floor muscles by enhancing the force generation, correct timing, and coordination of the pelvic floor muscles. Electromyography Biofeedback is considered as a behavioural therapy training modality
Balance training
functional strength, static and dynamic balance, and gait training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Sixty patients of both sexes were diagnosed with osteoporosis confirmed by bone density test through Dual-energy X-ray absorptiometry (DEXA) scan (A T-score equal to or less than - 2.5) (Sheu and Diamond, 2016).
2. Their age ranged between 65 - 75 years.
3. Their BMI ranged between 25 - 29.9 kg/m2.
4. They had good mentality and cognitive function.
Exclusion Criteria
1. Patients with endocrine disorders likely to be related to metabolic bone disease, such as premature ovarian failure, hypogonadism, untreated hyperthyroidism, hyperparathyroidism, adrenal insufficiency or Cushing's syndrome.
2. Patients with active contagious skin conditions.
3. Patients with implant devices such as pacemaker or electrical prosthesis.
4. Any cardiopulmonary disorders.
5. Any neuromuscular disorders.
6. Any acute viral infection.
7. Patients with ascites or end stage liver or kidney failure.
8. Leg discrepancy.
65 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mohamed Said Alsafy Alhamrawy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Said Alsafy Alhamrawy
Doctor
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P.T.REC/012/005451
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.